Retatrutide (10mg) - Lyophilized

Retatrutide is a novel triple incretin receptor agonist targeting GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon receptors simultaneously. Research has examined its effects on glucose homeostasis, energy expenditure, lipid metabolism, and body weight regulation in preclinical models. It represents an emerging area of research into multi-receptor metabolic modulation. Supplied as a lyophilized powder, 10 mg per vial. For research purposes only — not for human or veterinary use.